Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study

被引：0
|
作者：
Otte, C. [1 ]
Hinkelmann, K. [1 ]
Moritz, S. [1 ]
Yassouridis, A. [2 ]
Jahn, H. [1 ]
Wiedemann, K. [1 ]
Kellner, M. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
来源：
PHARMACOPSYCHIATRY | 2009年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A120
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [11] ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    ZAGNONI, PG
    BIANCHI, A
    ZOLO, P
    CANGER, R
    CORNAGGIA, C
    DALESSANDRO, P
    DEMARCO, P
    PISANI, F
    GIANELLI, M
    VERZE, L
    VIANI, F
    ZACCARA, G
    EPILEPSIA, 1994, 35 (01) : 107 - 112
  • [12] Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study
    Stenberg, Jan-Henry
    Terevnikov, Viatcheslav
    Joffe, Marina
    Tiihonen, Jari
    Tchoukhine, Evgueni
    Burkin, Mark
    Joffe, Grigori
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (04): : 433 - 441
  • [13] Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
    Miodownik, Chanoch
    Lerner, Vladimir
    Kudkaeva, Natalie
    Lerner, Paul P.
    Pashinian, Artashez
    Bersudsky, Yuly
    Eliyahu, Ronen
    Kreinin, Anatoly
    Bergman, Joseph
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (04) : 117 - 122
  • [14] L-Arginine Add-On Treatment for Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Kocyigit, Yasemin
    Yoca, Gokhan
    Karahan, Sevilay
    Ayhan, Yavuz
    Yazici, Mumin Kazim
    TURK PSIKIYATRI DERGISI, 2018, 29 (03) : 147 - 153
  • [15] Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study
    Brown, E. Sherwood
    Howard, Christina
    Khan, David A.
    Carmody, Thomas J.
    PSYCHOSOMATICS, 2012, 53 (01) : 75 - 80
  • [16] Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study
    Biederman, Joseph
    Lindsten, Annika
    Sluth, Lasse B.
    Petersen, Maria Louise
    Ettrup, Anders
    Eriksen, Hanne-Lise F.
    Fava, Maurizio
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (04) : 511 - 521
  • [17] Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chieh-Hsin
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 196 - 196
  • [18] The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
    Abdallah, Mahmoud Samy
    Eldeen, Ahmed Hossam
    Tantawy, Sally Said
    Mostafa, Tarek Mohamed
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906
  • [19] Dapagliflozin as Add-On Therapy to Sitagliptin With or Without Metformin: A Randomized, Double-Blind, Placebo-Controlled Study
    Jabbour, Serge
    Hardy, Elise
    Sugg, Jennifer
    Parikh, Shamik
    DIABETES, 2012, 61 : A275 - A276
  • [20] COGNITIVE AND ELECTROPHYSIOLOGICAL EFFECTS OF TIAGABINE ADD-ON THERAPY - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    RIEKKINEN, PJ
    KALVIAINEN, R
    AIKIA, M
    MERVAALA, E
    SAUKKONEN, AM
    PITKANEN, A
    NEUROLOGY, 1994, 44 (04) : A321 - A321
12345